Cyclooxygenase 2–derived prostaglandin E2 production by corticotropin‐releasing hormone contributes to the activated cAMP response element binding protein content in rheumatoid arthritis synovial tissue
Open Access
- 5 April 2004
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 50 (4) , 1132-1145
- https://doi.org/10.1002/art.20157
Abstract
Objective To determine a mechanism by which corticotropin-releasing hormone (CRH) promotes human inflammatory joint disease progression. Methods An ex vivo synovial tissue culture system was established to investigate the functional properties of CRH at peripheral sites of inflammation. CRH- and interleukin-1β (IL-1β)–induced prostaglandin E2 (PGE2) production from 10 fresh rheumatoid arthritis (RA) synovial tissue (ST) explants was quantified using a competitive enzyme-linked immunosorbent assay. Modulation of PGE2 levels was further examined following selective and nonselective cyclooxygenase 2 (COX-2) inhibition. Nuclear extracts were analyzed by electrophoretic mobility shift assays to determine functional cAMP response element binding protein (CREB) activity in response to CRH and PGE2 in isolated primary synovial cell populations. Western blot analysis measured levels of total and activated (phosphospecific) CREB/activating transcription factor (ATF) family members prior to and following stimulation. Results CRH, in a time- and dose-dependent manner, significantly (P = 0.022) up-regulated PGE2 production from 10 fresh RA ST explants. Costimulation of RA ST with CRH and IL-1β significantly augmented (P = 0.036) the effects on PGE2 production additively over 24 hours. We demonstrated that selective COX-2 inhibitors prevent the induction of PGE2 by both CRH and IL-1β. Further, we provided evidence that CRH and PGE2 signal through the induction of CREB and phosphorylated CREB/ATF family members in RA ST and in isolated primary RA cell populations. Conclusion Our findings underscore the pathogenic role that CRH may play in modulating inflammatory joint disease and establish the CREB/ATF family of transcription factors as principal effector molecules of proinflammatory mediator action in RA.Keywords
This publication has 47 references indexed in Scilit:
- Corticotropin-Releasing Hormone Augments Proinflammatory Cytokine Production from Macrophages In Vitro and in Lipopolysaccharide-Induced Endotoxin Shock in MiceInfection and Immunity, 2002
- Involvement of the nuclear orphan receptor NURR1 in the regulation of corticotropin-releasing hormone expression and actions in human inflammatory arthritisArthritis & Rheumatism, 2001
- NF-κB: a key role in inflammatory diseasesJournal of Clinical Investigation, 2001
- Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesisPublished by Wiley ,2000
- Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitroAnnals of the Rheumatic Diseases, 1998
- Characterization of SV40 T antigen immortalized human synovial fibroblasts: maintained expression patterns of EGR-i, HLA-DR and some surface receptorsRheumatology International, 1997
- Autocrine or Paracrine Inflammatory Actions of Corticotropin-Releasing Hormone in VivoScience, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Induction of cyclo‐oxygenase by interleukin‐1 in rheumatoid synovial cellsFEBS Letters, 1987
- Prostaglandin-stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis.Journal of Clinical Investigation, 1975